Insurers Shift Costs and Facts

As health insurance companies begin setting rates for 2019, many consumers are once again faced with skyrocketing premium hikes. Here’s how the insurance industry is responding.
Continuing to Deny Coverage
A new study from the University of Pennsylvania (UPenn) School of Medicine finds that insurance denials for hepatitis C drugs among patients with both private and public insurers remains high across the United States. As Dr. Vincent Lo Re III, associate professor of Infectious Disease an